While bone turnover markers were not available in this case, referenced studies report that both GIP and GLP-1 receptor agonists can stimulate parathyroid hormone (PTH) secretion in individuals with type 2 diabetes (6). Here, GLP1R is linked to type 2 diabetes mellitus.